Nephrol Dial Transplant (2001) 16: 1402-1408
© 2001 European Renal Association-European Dialysis and Transplant Association
Strong depletion of CD14+CD16+ monocytes during haemodialysis treatment
Medical Department IV, Nephrology, University of the Saarland, Homburg, Germany
Background. The immune defect in haemodialysis (HD) patients is associated with a monocytic dysfunction, including an increased production of proinflammatory cytokines. Monocytes fall into subpopulations comprising CD14++CD16- and CD14+CD16+ cells. Circulating numbers of the latter can rapidly increase during infectious episodes and inflammation.
Methods. We determined the amount of CD14+CD16+ monocytes in HD patients and characterized their fate during HD treatment. In 34 HD patients and 17 healthy controls, the distinct cell populations were determined by differential blood counts and flow cytometry. Cells from 14 HD patients were analysed at the start, 10, 30 and 120 min thereafter, and at the end of HD treatment.
Results. Before HD, patients show a monocytosis with a strongly increased CD14+CD16+ subpopulation. Early during HD treatment, circulating leukocyte numbers decrease, with monocytes being most profoundly influenced. Interestingly, among them, sequestration is most pronounced in the CD14+ CD16+ subpopulation. After 30 min, 
83±9% of CD14+CD16+ cells are removed from circulation. This sequestration does not differ between patients treated with polyamide or haemophan membranes. The sequestration is a short-lived temporary effect and cell numbers are replenished within 120 min of treatment for the entire monocyte population. Beyond that time point, cellular activation by the dialyser membrane becomes visible. Reappearence kinetics of CD14+CD16+ monocytes is slower; however, initial numbers are reached by the end of treatment.
Conclusion. Haemodiaysis leads to temporary removal of monocytes from the bloodstream followed by the reappearance of activated cells. This might contribute to the state of chronic microinflammation, which is reflected by high levels of CD14+CD16+ monocytes.
Keywords: CD14+CD16+ monocytes; flow cytometry; haemodialysis; inflammation
Correspondence and offprint requests to: Prof. Dr Hans Köhler, Medical Department IV, Nephrology, University Homburg, D-66421 Homburg, Germany.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. S. Rogacev, M. Ziegelin, C. Ulrich, S. Seiler, M. Girndt, D. Fliser, and G. H. Heine Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3480 - 3486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. E. Westerweel, I. E. Hoefer, P. J. Blankestijn, P. de Bree, D. Groeneveld, O. van Oostrom, B. Braam, H. A. Koomans, and M. C. Verhaar End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1132 - F1140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ziegler-Heitbrock The CD14+ CD16+ blood monocytes: their role in infection and inflammation J. Leukoc. Biol., March 1, 2007; 81(3): 584 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Carracedo, A. Merino, S. Nogueras, D. Carretero, I. Berdud, R. Ramirez, C. Tetta, M. Rodriguez, A. Martin-Malo, and P. Aljama On-Line Hemodiafiltration Reduces the Proinflammatory CD14+CD16+ Monocyte-Derived Dendritic Cells: A Prospective, Crossover Study J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2315 - 2321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ulrich, G. H. Heine, P. Garcia, B. Reichart, T. Georg, M. Krause, H. Kohler, and M. Girndt Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pertosa, S. Simone, M. Soccio, D. Marrone, L. Gesualdo, F. P. Schena, and G. Grandaliano Coagulation Cascade Activation Causes CC Chemokine Receptor-2 Gene Expression and Mononuclear Cell Activation in Hemodialysis Patients J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2477 - 2486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. M. Bouts, R. T. Krediet, J.-C. Davin, L. A. H. Monnens, J. Nauta, C. H. Schroder, J. G. J. van de Winkel, and T. A. Out IGG and complement receptor expression on peripheral white blood cells in uraemic children Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2296 - 2301. [Abstract] [Full Text] [PDF]
|
|